[96a5a0]: / output / allTrials / identified / NCT00339248_identified.json

Download this file

192 lines (192 with data), 8.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
{
"info": {
"nct_id": "NCT00339248",
"official_title": "Risk of Breast Cancer and Hyperplastic Conditions in the Breast Cancer Serum Bank in Relation to Inherited Genetic Variants",
"inclusion_criteria": "Healthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 15 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "* INCLUSION/EXCLUSION CRITERIA:\n\nPotentially eligible premenopausal women include 2636 who did not have a previous or concurrent (within 60 days) diagnosis of breast cancer at the time of initial benign breast biopsy (study entry) and who have at least 4 mls of serum stored in the Frederick biorepository.\n\nOf those 2636, four women have a code indicating \"refused study\" in the \"follow-up\" variable, and despite evidence of their consent to the original study, will be omitted from all future use of study data or specimens.\n\nParticipants also will be required to be Caucasian or African American (2599 or 98.6%), and to have a pathology report successfully retrieved from a participating hospital for review.\n\nAll sample sizes subsequently cited in the text take these inclusion criteria into account, and those cited for objective 2 also incorporate adjustment for loss to follow-up."
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 15 Years",
"criterions": [
{
"exact_snippets": "minimum age of 15 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 15,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "Potentially eligible premenopausal women include 2636 who did not have a previous or concurrent (within 60 days) diagnosis of breast cancer at the time of initial benign breast biopsy (study entry) and who have at least 4 mls of serum stored in the Frederick biorepository.",
"criterions": [
{
"exact_snippets": "premenopausal women",
"criterion": "menopausal status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "premenopausal"
}
]
},
{
"exact_snippets": "did not have a previous or concurrent (within 60 days) diagnosis of breast cancer",
"criterion": "breast cancer diagnosis",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": false
}
]
},
{
"exact_snippets": "at the time of initial benign breast biopsy (study entry)",
"criterion": "initial biopsy type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "benign"
}
]
},
{
"exact_snippets": "at least 4 mls of serum stored in the Frederick biorepository",
"criterion": "serum storage",
"requirements": [
{
"requirement_type": "volume",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "mls"
}
},
{
"requirement_type": "location",
"expected_value": "Frederick biorepository"
}
]
}
]
},
{
"line": "Of those 2636, four women have a code indicating \"refused study\" in the \"follow-up\" variable, and despite evidence of their consent to the original study, will be omitted from all future use of study data or specimens.",
"criterions": [
{
"exact_snippets": "code indicating \"refused study\" in the \"follow-up\" variable",
"criterion": "refusal to participate in follow-up",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "evidence of their consent to the original study",
"criterion": "consent to original study",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Participants also will be required to be Caucasian or African American (2599 or 98.6%), and to have a pathology report successfully retrieved from a participating hospital for review.",
"criterions": [
{
"exact_snippets": "Participants also will be required to be Caucasian or African American",
"criterion": "ethnicity",
"requirements": [
{
"requirement_type": "allowed_values",
"expected_value": [
"Caucasian",
"African American"
]
}
]
},
{
"exact_snippets": "pathology report successfully retrieved from a participating hospital for review",
"criterion": "pathology report",
"requirements": [
{
"requirement_type": "retrieval",
"expected_value": true
}
]
}
]
},
{
"line": "All sample sizes subsequently cited in the text take these inclusion criteria into account, and those cited for objective 2 also incorporate adjustment for loss to follow-up.",
"criterions": [
{
"exact_snippets": "loss to follow-up",
"criterion": "loss to follow-up",
"requirements": [
{
"requirement_type": "adjustment",
"expected_value": true
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "* INCLUSION/EXCLUSION CRITERIA:",
"criterions": []
}
]
}